NRx Pharmaceuticals’ subsidiary, HOPE Therapeutics, opened a new interventional psychiatry clinic in Palm Beach, Florida, on March 9 2026. The facility offers a one‑day treatment program that combines ketamine, other neuroplastic drugs, transcranial magnetic stimulation (TMS) and hyperbaric oxygen therapy with physician‑led psychotherapy.
The Palm Beach location is the latest addition to HOPE’s growing network, which aims to provide rapid, integrated care for depression and post‑traumatic stress disorder. The clinic’s opening follows the company’s strategy to generate revenue and build a national presence while its drug candidates advance through regulatory pathways. HOPE’s goal of operating six or more clinics by year‑end 2026 is a key milestone in the company’s hybrid platform, which blends drug development with direct patient care.
Financially, the clinic’s immediate impact is modest. In Q3 2025, HOPE’s clinics generated $240,000 in revenue, and the company had three revenue‑generating facilities in Florida, with a target of six or more by year‑end 2025. The Palm Beach clinic adds incremental revenue and helps diversify NRx’s cash flow while the company continues to pursue its drug pipeline, including NRX‑100 and NRX‑101, both of which have received Fast Track and Breakthrough Therapy designations for suicidal ideation and bipolar depression.
The clinic’s services—ketamine, other neuroplastic drugs, TMS and hyperbaric oxygen therapy—are designed to complement the company’s drug development efforts. By integrating these modalities into a single, physician‑led program, HOPE provides a platform for real‑world data collection that can support future regulatory submissions and strengthen the company’s overall value proposition.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.